Basic Suprax Information

• INN (International Nonproprietary Name): Cefixime.
• Brand Names Available In Australia: Suprax and various generics supplied as tablets and paediatric suspensions.
• ATC Code: J01DD08.
• Forms & Dosages: Tablets 400 mg; capsules 400 mg; chewable tablets 100 mg and 200 mg; oral suspension 100 mg/5 mL and 200 mg/5 mL.
• Manufacturers In Australia: Not specified.
• Registration Status In Australia: Not specified.
• OTC / Rx Classification: Prescription-only (Rx) in observed markets.

Key Findings From Recent Trials

Major 2022–2025 Australian & Global Studies

Clinicians are asking whether cefixime still works for routine infections and whether it remains an option for gonorrhoea.

Recent surveillance and trial literature (2022–mid‑2025) shows two clear trends for cefixime.

The drug retains good utility for uncomplicated community infections such as urinary tract infections and otitis media.

At the same time, rising minimum inhibitory concentrations in Neisseria gonorrhoeae are evident in Australian and international datasets.

Australian surveillance summaries (AGSP and state labs 2022–24) document increasing MICs that have driven guideline changes in many regions.

Randomised trials and meta-analyses since 2022 support oral cefixime as non‑inferior to comparator oral cephalosporins for selected community indications.

These trials report similar clinical cure rates for uncomplicated UTI and otitis media when local susceptibility supports use.

Guideline bodies now recommend against routine cefixime monotherapy for gonorrhoea where resistance or elevated MICs are documented.

Prescribers are advised to consult local antibiograms before choosing cefixime for sexually transmitted infections.

Common search interests include cefixime resistance, gonorrhoea MIC trends and AGSP surveillance updates.

Main Outcomes

Uncomplicated community infections respond well to appropriately dosed oral cefixime in recent trials.

Meta-analyses show non-inferiority to other oral third‑generation cephalosporins for defined populations and durations.

In paediatrics, once‑daily suspension regimens improved adherence without loss of efficacy for otitis media in selected patients.

For gonorrhoea, single‑dose cefixime (historically 400 mg) now has limited role without susceptibility confirmation.

Local stewardship teams increasingly flag cefixime as a second‑line oral cephalosporin for community infections.

Prescribers should pair trial evidence with contemporary local resistance data when selecting therapy.

Safety Observations (TGA Reports)

TGA adverse event summaries from 2022–24 align with global post‑market reporting patterns.

Gastrointestinal events are the most frequently reported adverse effects, with diarrhoea and nausea predominating.

Rare but serious adverse events reported include hypersensitivity reactions and isolated cases of Clostridioides difficile colitis.

No new major organ‑toxicity signals emerged in the surveillance window.

The pharmacovigilance picture supports continued cautious use, with prompt reporting to TGA for serious events.

Clinical Mechanism Of Action

Layman’s Explanation

People often ask how cefixime actually kills bacteria.

Think of cefixime as stopping bacteria from building a sturdy outer shell so they burst when stressed.

The effect is bactericidal rather than merely stopping growth.

That simple picture helps explain why timely dosing matters for success.

Scientific Breakdown

Molecular Target And Bactericidal Action

Cefixime is a third‑generation cephalosporin that binds penicillin‑binding proteins (PBPs).

Binding inhibits transpeptidation and peptidoglycan cross‑linking in the bacterial cell wall.

The resulting cell wall defect leads to bactericidal activity through osmotic lysis.

Activity is particularly useful against many gram‑negative organisms compared with older cephalosporins.

Pharmacokinetic Highlights

Oral bioavailability of cefixime is moderate and can vary with food and formulation.

Typical adult regimens are 400 mg once daily or 200 mg twice daily depending on the indication.

Renal excretion predominates, so dose reduction is advised when creatinine clearance is under 60 mL/min.

Probenecid can raise serum cefixime concentrations by reducing tubular secretion.

Time above the minimum inhibitory concentration (T>MIC) predicts efficacy, emphasising the importance of regular dosing.

Scope Of Approved & Off‑Label Use

Australian Approvals (TGA‑Listed, PBS Inclusion)

Cefixime (Suprax and generics) is a prescription systemic third‑generation cephalosporin, ATC J01DD08.

TGA registration details specific to Australia are not specified in the supplied source.

PBS listing for cefixime is limited and variable by presentation and state authority rules.

Clinicians commonly obtain cefixime via private prescription when a PBS listing is absent.

Where PBS alternatives exist, prescribers may prefer subsidised agents for cost reasons and stewardship.

Notable Off‑Label Trends In Australian Practice

Australian GPs and rural clinicians sometimes use cefixime off‑label for paediatric otitis media when adherence to multiple‑dose alternatives is poor.

Outpatient management of mild community UTIs with cefixime occurs when local antibiograms support susceptibility.

For gonorrhoea, national sexual health guidance warns against routine cefixime monotherapy because of resistance concerns.

Cefixime may still be used in select gonorrhoea cases only with confirmed susceptibility data.

Prescribers should check local antimicrobial stewardship policies and PBS rules before prescribing non‑subsidised cefixime.

Dosage Strategy

General Dosing

The usual adult dose is 400 mg once daily or 200 mg twice daily depending on formulation and severity.

Paediatric dosing is typically 8 mg/kg once daily or 4 mg/kg every 12 hours for children 6 months to 12 years.

Elderly patients require monitoring for renal decline but do not have a fixed age‑based dose reduction.

When creatinine clearance is less than 60 mL/min reduce dose by about 50% and monitor kidney function.

Condition‑Specific Dosing (PBS Recommendations)

Uncomplicated UTI: 400 mg once daily for commonly 5–7 days depending on clinical response.

Acute otitis media: 400 mg once daily for 5–10 days in older children and adults where indicated.

Pharyngitis/tonsillitis: 400 mg once daily for 5–10 days according to prescriber advice.

Gonorrhoea: single 400 mg dose was historically used, but current practice requires susceptibility guidance and avoidance of monotherapy where resistance is documented.

Where cefixime is not PBS‑subsidised clinicians may issue private scripts or seek special authority for restricted indications.

Safety Protocols

Contraindications (Australian Guidelines)

Absolute contraindications include known severe hypersensitivity to cefixime, cephalosporins or formulation excipients.

A history of severe immediate penicillin allergy warrants caution due to potential cross‑reactivity.

Use with caution in significant renal impairment, prior C. difficile infection, and severe hepatic dysfunction.

Pregnancy is category B; use only when clearly indicated after discussing risks and benefits.

Adverse Effects (Post‑Market Pharmacovigilance)

Common adverse effects reported include diarrhoea, abdominal pain, nausea and cutaneous reactions.

Rare but serious events reported to TGA and international databases include anaphylaxis and Stevens‑Johnson syndrome.

Cases of C. difficile colitis have been reported after broad‑spectrum cephalosporin use and require immediate review.

Clinicians should report suspected serious adverse reactions to the TGA’s DAEN system to support ongoing safety monitoring.

Interaction Mapping

Food Interactions (Alcohol, Coffee, Diet In Australia)

Some formulations of cefixime can be taken with or without food, although absorption is moderately affected by meals.

There is no specific disulfiram‑type interaction with alcohol, but alcohol can worsen gastrointestinal side effects.

Coffee and typical Australian diets do not alter cefixime efficacy in routine use.

Drug Combinations To Avoid (TGA Safety Alerts)

Probenecid reduces renal tubular secretion and raises cefixime serum levels, which is clinically relevant.

Concurrent use with nephrotoxic drugs requires renal monitoring.

Cephalosporins can rarely potentiate anticoagulant effects of warfarin; check INR when starting or stopping cefixime.

Avoid combining cefixime with bacteriostatic antibiotics for serious infections without specialist advice.

Patient Experience Analysis

Australian Survey Data

Patients often ask for once‑daily cefixime because it is easier to manage than multiple daily doses.

Surveys and pharmacy feedback from 2022–25 show high satisfaction with once‑daily regimens, particularly for paediatric suspensions.

Common complaints mirror the adverse event profile: diarrhoea, nausea and transient rashes are most frequent.

Rural patients report that once‑daily dosing helps when GP appointments are delayed and adherence support falls to pharmacists.

Forum And Pharmacy Trends

Community pharmacies such as Chemist Warehouse, Priceline and TerryWhite report steady demand for private‑script cefixime.

Price sensitivity is notable where PBS subsidy is absent and generic options are compared at the counter.

Online forums and telehealth patients frequently request cefixime for UTI or children’s ear infections driven by prior positive experiences.

Pharmacists increasingly focus counselling on adherence, storage in hot Australian summers and red‑flag symptoms for allergic reactions or C. difficile.

Distribution & Pricing Landscape

National Pharmacy Chains (Chemist Warehouse, Priceline, TerryWhite)

Cefixime is available through national chains and independent pharmacies in tablet and suspension forms.

Chains commonly stock generics and advertise competitive private‑script pricing when PBS subsidy is not available.

Rural pharmacies may charge higher dispensing fees and have limited stock, affecting out‑of‑pocket cost for patients.

Online Pharmacy Growth And Telehealth E‑Scripts

Telehealth and e‑scripts have increased access to cefixime since 2020, with home delivery options growing in popularity.

In our online pharmacy, suprax is available without a prescription, with discreet delivery to Australia in 5-14 days.

Prescriber verification and PBS subsidisation remain the main determinants of subsidy eligibility for patients.

PBS Vs Private Cost Comparisons

Where cefixime is not PBS‑listed, private script prices vary by brand and formulation and may be a significant cost to patients.

Subsidised alternatives listed on the PBS can dramatically reduce costs and are often preferred when clinically appropriate.

Pharmacists can advise on generic options and concession card eligibility to reduce patient expense.

Alternative Options

Comparison Table Of PBS And Non‑PBS Options

Common PBS‑listed oral antibiotics for similar indications include amoxicillin, amoxicillin/clavulanate and cefuroxime depending on local listings.

Non‑PBS options commonly chosen include cefixime on private prescription and imported generics that may be cheaper but lack subsidy.

Choose antibiotics according to local antibiogram data and PBS availability to balance stewardship and cost.

Pros And Cons Checklist

Cefixime Pros: once‑daily convenience, useful third‑generation activity, paediatric suspension available.

Cefixime Cons: limited PBS subsidy, rising gonococcal resistance and broader spectrum than narrow agents.

Alternatives Pros: PBS coverage, often narrower spectrum and established stewardship pathways.

Alternatives Cons: Some require more frequent dosing or cause different tolerance issues (e.g., Augmentin and GI upset for some patients).

Document rationale when prescribing non‑PBS cefixime and check local resistance patterns.

Regulatory Status

TGA Approval Framework

Cefixime formulations are registered medicines under the Therapeutic Goods Administration framework in global contexts, with prescription‑only status observed in supplied data.

Sponsors must demonstrate quality, safety and efficacy and fulfil post‑market obligations.

TGA listing controls supply, labelling and prescription classification for marketed products.

PBS Subsidy Process

PBS subsidy requires a separate application and negotiation with the Department of Health and Aged Care demonstrating cost‑effectiveness and defined indications.

Because multiple generic suppliers exist globally, cefixime has limited PBS listing for many formulations in the supplied dataset.

Clinicians should check the PBS Schedule and authority requirements for current subsidy status before prescribing.

Consolidated FAQ

Is Suprax (cefixime) on the PBS?

Cefixime is prescription‑only and PBS subsidy is limited and variable, so many patients pay private script prices; ask your pharmacist or check the PBS Schedule.

Can I drink alcohol while taking cefixime?

No disulfiram‑type interaction is reported, but alcohol may worsen gastrointestinal side effects and delay recovery, so it is best avoided during treatment.

Is cefixime safe for children?

Paediatric suspensions are commonly used for children over 6 months with dosing around 8 mg/kg once daily; follow the prescriber’s directions exactly.

What if I miss a dose?

Take a missed dose as soon as remembered unless it is nearly time for the next dose; do not double up to catch up.

When should I see a doctor?

Seek urgent review for worsening symptoms, high fever, signs of allergic reaction or severe diarrhoea that could indicate C. difficile.

Visual Guide

Visuals make it easier for patients to compare costs and understand storage and dosing obligations.

Suggested infographic 1: PBS Versus Private Cost Bar Chart contrasting amoxicillin, Augmentin and private cefixime prices with concession scenarios.

Suggested infographic 2: Australia Map showing pharmacy density, urban versus rural access and typical wait times for scripts with telehealth coverage highlighted.

Suggested infographic 3: Adherence Flowchart contrasting once‑daily versus multiple‑daily dosing, renal dose adjustments and when to seek help.

Suggested infographic 4: Side‑Effect Quickcard with icons for diarrhoea, rash and red flags like anaphylaxis and severe diarrhoea.

Ensure alt text, colour‑blind‑friendly palettes and plain‑language legends for patient materials.

Storage & Transport

Household Storage Under Australian Climate

Store tablets and capsules at controlled room temperature, ideally 15–30°C and protected from moisture and direct sunlight.

Avoid storing medicines in cars or near windows during hot Australian summers, because temperatures can exceed recommended limits.

Label reconstituted suspensions with the date and keep them refrigerated, discarding any unused suspension after 14 days.

Advise patients to use insulated bags for transport in hot weather when collecting from the pharmacy.

Cold‑Chain Logistics For Pharmacies

Unreconstituted suspensión powders and tablets are stored at room temperature as per supplier instructions.

Once oral suspensions are reconstituted, refrigerators should be maintained at 2–8°C and stock rotation enforced.

Rural pharmacies may reconstitute in small batches during supply disruptions and should carefully track expiry dates.

If substitutes are required, counsel patients on stability differences and safe disposal of expired products.

Guidelines For Proper Use

Pharmacist Counselling Style In Australia

Counselling should be concise and evidence‑based while covering indication, dose, renal function and allergy history.

Explain why adherence matters (T>MIC) and review common side effects and red‑flag symptoms that require immediate attention.

Use teach‑back for paediatric dosing and provide clear written instructions for reconstituting and discarding suspensions.

National Health Authority Recommendations

Align prescribing with RACGP, ASHM and local health district antimicrobial stewardship policies.

Avoid cefixime for suspected viral infections and verify susceptibility for gonorrhoea before using cefixime as monotherapy.

For remote patients, coordinate care between telehealth prescribers and local pharmacists and document reasons for non‑PBS prescribing.

Report adverse events to the TGA and prioritise narrow‑spectrum agents where appropriate to limit resistance pressure.

Delivery Across Australia

Final Notes On Stewardship And Buying

Only prescribe or supply cefixime when bacterial infection is likely and susceptibility is considered.

Keep in mind rising cefixime resistance in gonorrhoea and use local antibiograms for decision making.

When cefixime is chosen, document clinical rationale, chosen dose and expected duration on the prescription record.

If cost is an issue, discuss PBS alternatives and generic options with the patient before issuing a private script.

Report any serious adverse events to the TGA to contribute to national pharmacovigilance data.